D.E. Shaw & Co’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.57M | Buy |
412,896
+62,977
| +18% | +$850K | ﹤0.01% | 1371 |
|
|
2025
Q1 | $3.03M | Buy |
349,919
+54,202
| +18% | +$469K | ﹤0.01% | 1623 |
|
|
2024
Q4 | $1.44M | Buy |
295,717
+32,062
| +12% | +$156K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $2.04M | Sell |
263,655
-44,679
| -14% | -$345K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $3.08M | Sell |
308,334
-40,558
| -12% | -$406K | ﹤0.01% | 1517 |
|
|
2024
Q1 | $4.24M | Sell |
348,892
-113,615
| -25% | -$1.38M | ﹤0.01% | 1362 |
|
|
2023
Q4 | $6.62M | Sell |
462,507
-137,886
| -23% | -$1.97M | 0.01% | 1069 |
|
|
2023
Q3 | $4.67M | Buy |
600,393
+64,414
| +12% | +$501K | ﹤0.01% | 1221 |
|
|
2023
Q2 | $7.66M | Buy |
535,979
+64,747
| +14% | +$925K | 0.01% | 1035 |
|
|
2023
Q1 | $6.89M | Buy |
471,232
+286,250
| +155% | +$4.19M | 0.01% | 1151 |
|
|
2022
Q4 | $3.11M | Buy |
184,982
+100,553
| +119% | +$1.69M | ﹤0.01% | 1767 |
|
|
2022
Q3 | $1.25M | Buy |
+84,429
| New | +$1.25M | ﹤0.01% | 2425 |
|
|
2021
Q2 | – | Sell |
-8,838
| Closed | -$431K | – | 3697 |
|
|
2021
Q1 | $431K | Sell |
8,838
-10,385
| -54% | -$506K | ﹤0.01% | 2547 |
|
|
2020
Q4 | $599K | Buy |
+19,223
| New | +$599K | ﹤0.01% | 2223 |
|